| Cash Flow | 2025-09-30 |
|---|---|
| Income (loss) from continuing operations before income taxes, noncontrolling interest | 114,715 |
| Net income tax effect | 23,756 |
| Net income | 90,959 |
| Esop and stock-based compensation expense | 9,646 |
| Depreciation and amortization | 23,048 |
| Deferred income taxes | 1,352 |
| Provision (credit) for loan losses | 2,500 |
| Net gain on the sale of loans | 5,342 |
| Other net (gains) losses | 19 |
| Proceeds from sale, loan, held-for-sale | 116,226 |
| Loans originated for sale | 133,102 |
| Payments for (proceeds from) bank owned life insurance policies | 10,663 |
| Increase (decrease) in accounts receivable and other operating assets | -1,039 |
| Net increase in accrued expenses and other liabilities | -13,225 |
| Net cash provided by operating activities | 82,419 |
| Loans originated or acquired | 3,786,379 |
| Principal repayments on loans | 3,122,822 |
| Securities available for sale | 170,342 |
| Proceeds from securitization, loan, held-for-sale | 284,777 |
| Real estate owned | 193 |
| Proceeds from sale of federal home loan bank stock | 24,582 |
| Fhlb stock | 31,451 |
| Purchase of securities available for sale | 160,342 |
| Premises, equipment, and software | 11,453 |
| Other | -2,927 |
| Cash provided by (used in) investing activity, including discontinued operation | -383,982 |
| Net change interest-bearing deposits, domestic | 260,619 |
| Net increase (decrease) in borrowers' advances for insurance and taxes | -469 |
| Net change noninterest-bearing deposits, domestic | 1,575 |
| Fair value of plan assets | 283,000 |
| Increase (decrease) in federal funds purchased | 0 |
| Proceeds from long-term borrowed funds | 225,000 |
| Repayment of long-term borrowed funds | 427,000 |
| Cash collateral/settlements (provided to) received from derivative counterparties | -11,931 |
| Acquisition or net settlement of treasury shares | 3,977 |
| Dividends paid to common shareholders | 59,533 |
| Net cash provided (used in) by financing activities | 267,284 |
| Net increase (decrease) in cash and cash equivalents | -34,279 |
| Cash and cash equivalents at beginning of period | 463,718 |
| Cash and cash equivalents at end of period | 429,439 |
TFS Financial CORP (TFSL)
TFS Financial CORP (TFSL)